Drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres for treatment of unresectable intrahepatic cholangiocarcinoma
Conclusion: DEB-TACE with CSM is safe and well-tolerated for unresectable ICC patients, with a low complication rate and a relative benefit in terms of survival. Subsequent treatments including systemic/loco-regional treatments is an independent favorable prognostic factor, but cholangiectasis, extensive intrahepatic tumor burden and extrahepatic metastases are the three prognostic factors associated with poor survival.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Tan-Yang Zhou, Guan-Hui Zhou, Yue-Lin Zhang, Chun-Hui Nie, Tong-Yin Zhu, Hong-Liang Wang, Sheng-Qun Chen, Bao-Quan Wang, Zi-Niu Yu, Li-Ming Wu, Shu-Sen Zheng, Jun-Hui Sun Tags: Research Paper Source Type: research
More News: Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Liver | Pain | Study | Urology & Nephrology